Thomas Simon H L
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Br J Clin Pharmacol. 2012 Jun;73(6):878-83. doi: 10.1111/j.1365-2125.2012.04229.x.
Clinical toxicology concerns the investigation, diagnosis and management of suspected poisoning. It is an important discipline because of the frequency of suspected poisoning, including drug overdose. In the UK, most episodes are managed by nonspecialists, with support provided online or by telephone from the National Poisons Information Service. Leadership and clinical support for this is provided by a small number of clinical toxicologists, who are almost invariably accredited specialists in clinical pharmacology and therapeutics. Priorities for maintaining and enhancing clinical toxicology as a subspeciality in the UK include: 1 Maintaining funding for poisons centres. This is essential in spite of current budgetary pressures. 2 Formal training in the discipline. The 1 year optional training module in clinical toxicology approved in 2011 as part of the clinical pharmacology and therapeutics curriculum represents important progress, but funding for appropriate programmes and accreditation for trainees from other relevant disciplines is needed. Arrangements for registration and revalidation are also required. 3 An improved evidence base for management of poisoning. Priority areas include continued surveillance of the epidemiology and outcomes of poisoning, including syndromic surveillance, more rapid characterization of the human toxicity of newly introduced medicines and better clinical evidence on use of antidotes and other treatments; for example, acetylcysteine and lipid emulsion therapy.
临床毒理学关注疑似中毒的调查、诊断和处理。由于疑似中毒(包括药物过量)的发生频率较高,它是一门重要的学科。在英国,大多数中毒事件由非专科医生处理,国家毒物信息服务中心通过网络或电话提供支持。少数临床毒理学家为此提供领导和临床支持,他们几乎无一例外都是临床药理学和治疗学方面的认可专家。在英国,将临床毒理学作为一个亚专业进行维持和加强的优先事项包括:1. 维持毒物中心的资金。尽管目前存在预算压力,但这至关重要。2. 该学科的正规培训。2011年批准的作为临床药理学和治疗学课程一部分的为期1年的临床毒理学选修培训模块是一项重要进展,但需要为适当的课程提供资金,并为来自其他相关学科的学员提供认证。还需要进行注册和重新验证的安排。3. 改善中毒处理的证据基础。优先领域包括持续监测中毒的流行病学和结果,包括症状监测,更快地确定新引入药物的人体毒性,以及关于解毒剂和其他治疗方法(如乙酰半胱氨酸和脂质乳剂治疗)使用的更好临床证据。